|
|
||||||||
1 From the Department of Ophthalmology, Tokyo Dental College, Chiba, Japan; and the 2 Department of Transplantation Immunology, Tokai University School of Medicine, Kanagawa, Japan.
| Abstract |
|---|
|
|
|---|
METHODS. Epithelial cells on the paracentral cornea in patients who have undergone LAT were subjected to fluorescence in situ hybridization (FISH) and polymerase chain reaction restriction fragment length polymorphism (RFLP) analysis. X and Y chromosomes were detected using sex chromosomespecific probes in the FISH analysis, and HLA-DPB1 antigens were examined in the RFLP analysis. Eyes receiving conventional penetrating keratoplasty (PKP) served as controls.
RESULTS. Donor-derived epithelial cells were detected in three of five eyes (60.0%) in the FISH analysis and in seven of nine eyes (77.8%) in the RFLP analysis. Among these eyes, one and three eyes in the FISH and RFLP analysis, respectively, had both donor- and recipient-derived cells. In control PKP eyes, none of the eyes in the FISH analysis and one of eight eyes (12.5%) in the RFLP analysis had donor-derived cells.
CONCLUSIONS. These results suggest that donor-derived cells survive much longer after LAT than those after PKP, and that LAT may function as stem cell transplantation of the corneal epithelium.
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
|
|
After LAT, dexamethasone (Rinderon; Shionogi Pharmaceutical, Osaka,
Japan) was administered with a starting dose of 8 mg/d and tapered
within 3 weeks, and cyclosporin A (Sandimmune, Sandoz, Basel,
Switzerland) was administered intravenously with a starting dose of 3
mg/kg for 1 week, with trough levels of 100 to 150 ng/ml maintained for
at least 6 months. Topical antibiotics (0.3% ofloxacin, Tarivid;
Santen Pharmaceutical, Osaka, Japan), corticosteroid (0.1%
dexamethasone, Sanbetason; Santen Pharmaceutical), autoserum dissolved
in physiological saline, and 0.05% cyclosporin A dissolved in
-cyclodextrin were used five times a day. In patients who underwent
PKP without LAT, systemic cyclosporin A was not used. Systemic
administration of corticosteroid and/or topical cyclosporin A was used
in some cases.
Clinical Sampling
Epithelial cells in the paracentral cornea (approximately 0.5 mm
in diameter) in the inferotemporal region were obtained using fine
forceps. For the FISH analysis, cells were placed on a glass slide with
saline, then dried, and fixed with absolute alcohol. For the RFLP
analysis, the samples were placed in microtubes with physiological
saline and kept frozen until analysis.
FISH
Samples slides were treated with 100 mg/ml RNase A in 2x SSC at
37°C for 1 hour, incubated with 0.01 N HCl containing 50 mg/ml pepsin
for 10 minutes at 37°C, and fixed with 1% formaldehyde in
phosphate-buffered saline (PBS) containing 50 mM MgCl2.
After washing with PBS, cells were dehydrated in an ethanol series and
then denatured by incubating in 70% formaldehyde and 2x SSC at 71°C
for 2 minutes.
FISH was performed with sex chromosomespecific dual color probe (CEP X SpectrumOrange/CEP Y SpectrumGreen; Vysis, Downers Grove, IL). Hybridization using each probe was carried out according to the manufacturers recommendation. The samples were counterstained with 4',6-diamimo-2-phenylindole (DAPI). Signals from fluorescein isothiocyanate (FITC), rhodamine, the two color probes, and DAPI were visualized by fluorescence microscope (Nikon, Tokyo, Japan) with triple-band-pass filter. X chromosomes were visualized as red signals, and Y chromosomes as green. Typically, 20 to 50 cells were examined in each sample.
RFLP Analysis
Genomic DNAs from the sample cells were extracted by the
conventional phenolchloroform method. HLA-DPB1 alleles were genotyped
by the polymerase chain reactionrestriction fragment length
polymorphism (PCR-RFLP) method.11
A test typing kit
(Sumitomo Metal Industries, Tokyo, Japan) was used. In brief, the
reaction mixture containing 0.5 mg genomic DNA, 10 µl 10x PCR
buffer, 10 µl solution containing dNTPs, mixed primers, 2.5 U
Taq polymerase (TakaraTaq; Takara Shuzo, Shiga, Japan) and
MilliQ water for a total volume of 100 ml, was covered with 1
drop of mineral oil in a 0.5-ml microcentrifuge tube. PCR
amplifications were carried out by 30 cycles of 96°C denaturation (60
seconds), 56°C annealing (60 seconds), and 72°C extension (120
seconds), followed by an additional extension (72°C, 5 minutes), in
an automated oil-bath PCR thermal sequencer (model TSR-300; Iwaki
Glass, Chiba, Japan). After PCR, 5-µl aliquots of the PCR product
with 1.5 µl of gel loading buffer were checked for amplification by
10% acrylamide gel electrophoresis in 0.5x TBE buffer in MUPID (Cosmo
Bio, Tokyo, Japan). When the DNA sample was amplified for the
target DPB1 loci, 10-µl aliquots of the PCR product were digested
with enzyme solution, which contained 2 U restriction endonucleases and
reaction buffer solution, for 3 hours to overnight at 37°C. Seven
restriction enzymes (Bsp1286I, BssHII,
Cfr13I, DdeI, EcoNI, FokI
and RsaI) were used. Three milliliters gel loading buffer
with proteinase K (Boehringer Mannheim, Mannheim, Germany) was added
and incubated for 30 minutes at 37°C. The digested fragments were
detected by 10% acrylamide gel electrophoresis, and the allelic types
were determined from the RFLP patterns.
| Results |
|---|
|
|
|---|
FISH Analysis
Three of five samples contained epithelial cells with
donor-derived chromosomes (Table 1)
. Figure 1
A shows the fluorescence micrograph of a 69-year-old man with ocular
cicatricial pemphigoid who had LAT from a female donor (case 3). All
cells in the sample, which were collected at 99 weeks after surgery,
showed two red fluorescence signals in each cell, indicating that these
cells were of donor origin. Two other samples (cases 1 and 4) also
showed the presence of donor-derived cells. In case 1, 14 of 15 cells
collected showed both X and Y chromosomes (donor origin, Fig. 1B
), and
only one cell had two X chromosome signals (recipient origin). The
remaining two cases had only host-derived cells, which corresponded to
the two cases that had either postoperative conjunctival invasion
or corneal neovascularization. Cells from the nine PKP cases were
all of host origin (Table 3
; Fig. 1C
).
|
|
Discussion
In the present study, we showed that donor-derived corneal
epithelium survived much longer in patients who underwent LAT plus PKP
than in those who underwent PKP alone. Combined results from both FISH
and RFLP analysis revealed that 7 of 10 eyes had donor-derived cells,
of which three eyes had both donor- and recipient-derived cells (Table 3)
. Both FISH and RFLP analyses were shown to be very
sensitive12
13
and allowed the determination of the
origins of cells from small samples. Results of the two-analysis method
were in good accordance. In four eyes examined by both FISH and RFLP
analysis, three showed the same results in the survival of donor cells.
One eye showed only recipient cells in the FISH analysis and a mixture
of both donor and recipient in RFLP analysis. Therefore, it is highly
likely that these results reflected the real status of the graft
epithelial cells.
In contrast to the high rate of donor cell survival after LAT, all but one PKP eye had only recipient-derived cells. The result is in good accordance with previous reports, which showed that the donor graft epithelial cells are gradually replaced by recipient cells within 1 year after surgery. Kinoshita et al.7 studied the survival of donor corneal epithelium using sexchromatin analysis in rabbits after lamellar keratoplasty and found that donor cells survived only up to 12 weeks after surgery.7 Similar results were reported in human eyes using the FISH analysis.8
The stem cells of the corneal epithelium are located in the limbal area, and they constantly produce transient amplifying cells. The basal cells have a high capacity of proliferation, but their life span is limited to several months. The corneal epithelial cells, other than basal cells, are terminally differentiated cells, and their life span is only approximately 1 week. All conventional keratoplasties, including PKP, lamellar keratoplasty, and keratoepithelioplasty, are transplantations of transient amplifying cells and terminally differentiated cells.14 Therefore, it is understandable that donor epithelium is depleted within several months after surgery. The results of the present study in which donor epithelial cells were detected up to 30 months after LAT strongly suggest that LAT functions as a stem cell transplantation.
Although the clinical success of LAT is remarkable, previous studies failed to show the long-term survival of donor-derived cells after LAT. Swift et al.10 studied donor cell survival in rabbit limbal dysfunction models using sexchromatin analysis. They showed that the number of epithelial cells positive for the Barr body (female origin) was not significantly different in female rabbits receiving LAT from male donors than in control animals. The most probable reason that we found more donor-derived cells than Swift et al. is the difference in postoperative treatment. Relatively strong postoperative immunosuppression was used in our study, whereas topical steroid was used only in a subgroup of animals.10
Interestingly, in Swift et al., more donor-derived epithelial cells were observed in eyes receiving topical steroid than in those that did not. We believe that intense care against immunologic rejection is a key to longer survival of donor-derived epithelial cells. In human studies, Williams et al.9 investigated the survival of donor-derived epithelial cells in an LAT patient using short tandemrepeat DNA polymorphism. They reported that donor-derived cells were detected at the 12th postoperative week but disappeared by the 20th week, despite strong systemic immunosuppression. One possible explanation is that they placed limbal grafts segmentally (from 4 to 8 oclock and 10 to 2 oclock). Host cells may therefore have invaded the central cornea through nasal and temporal openings of the limbal grafts. In our experience, a ring-shaped graft blocks conjunctival invasion to the cornea more efficiently than do segmentally placed grafts.
Interestingly, some of the samples in our series had both donor and recipient cells. It is not clear whether this coexistence of donor and recipient cells is a stable condition or represents slow but continuous replacement of donor-to-recipient cells. Recent studies show that persistence of donor-derived cells after organ transplantation is a relatively common phenomenon when molecular analysis is used (microchimerism).12 13 15 Whether the chimeric distribution on the cornea contributes to the graft acceptance in LAT, as is postulated in liver transplantation,15 is unclear. The limbal area of eyes undergoing LAT was totally covered by fibrous tissues before surgery that was completely excised during surgery. Therefore, recipient limbal stem cells are unlikely to survive, and recipient-derived cells found in the samples were presumably of host conjunctival epithelium origin. Phenotypic change of the conjunctival to corneal epithelium has been observed when limbal cells are totally destroyed.16 We did not find any differences in clinical outcomes, including the development of postoperative complications between eyes with or without donor-derived epithelial cells. More studies are needed to elucidate the clinical significance in donor cell survival.
In conclusion, the present study indicates that donor-derived corneal epithelium survived for up to 30 months after LAT, which is significantly longer than conventional keratoplasty. LAT is likely to function as a stem cell transplantation of the corneal epithelium.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by grants from the Japanese Ministry of Health and Welfare and in part by a Grant-in-Aid for Research supported by Tokyo Dental College.
Submitted for publication July 7, 1998; revised January 22, 1999; accepted March 3, 1999.
Proprietary interest category: N.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Lagali, U. Stenevi, M. Claesson, P. Fagerholm, C. Hanson, B. Weijdegard, and the Swedish Society of Corneal Surgeons Survival of Donor-Derived Cells in Human Corneal Transplants Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2673 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Jamali, S. L. Hatcher, and Z. You Donor Cell Survival in a Fresh Osteochondral Allograft at Twenty-nine Years. A Case Report J. Bone Joint Surg. Am., January 1, 2007; 89(1): 166 - 169. [Full Text] [PDF] |
||||
![]() |
Y. Ogawa, H. Kodama, K. Kameyama, K. Yamazaki, H. Yasuoka, S. Okamoto, H. Inoko, Y. Kawakami, and M. Kuwana Donor Fibroblast Chimerism in the Pathogenic Fibrotic Lesion of Human Chronic Graft-Versus-Host Disease Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4519 - 4527. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Djalilian, S. P. Mahesh, C. A. Koch, R. B. Nussenblatt, D. Shen, Z. Zhuang, E. J. Holland, and C.-C. Chan Survival of Donor Epithelial Cells after Limbal Stem Cell Transplantation Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 803 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishida, M. Yamato, Y. Hayashida, K. Watanabe, K. Yamamoto, E. Adachi, S. Nagai, A. Kikuchi, N. Maeda, H. Watanabe, et al. Corneal Reconstruction with Tissue-Engineered Cell Sheets Composed of Autologous Oral Mucosal Epithelium N. Engl. J. Med., September 16, 2004; 351(12): 1187 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. D. Mills, D. J. Coster, and K. A. Williams Effect of Immunosuppression on Outcome Measures in a Model of Rat Limbal Transplantation Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 647 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R M Henderson, D. J Coster, and K. A Williams The long term outcome of limbal allografts: the search for surviving cells Br J Ophthalmol, May 1, 2001; 85(5): 604 - 609. [Abstract] [Full Text] |
||||
![]() |
I. R. Schwab and R. R. Isseroff Bioengineered Corneas -- The Promise and the Challenge N. Engl. J. Med., July 13, 2000; 343(2): 136 - 138. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |